Back to search
FDAFDA · Food and drugs·Recall number D-0611-2025

DermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08

Published September 10, 2025 · Recall initiated: July 17, 2025

Summary

FDA records drug Class I recall D-0611-2025, published September 10, 2025 and initiated July 17, 2025. Recalling firm: DermaRite Industries, LLC; Status: Ongoing; Reported quantity: 249 bottles; Lot: Lot #: 40187.2, Exp. Date 2/2026. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
DermaRite Industries, LLC
Distributor
Nationwide within the USA
Lot
Lot #: 40187.2, Exp. Date 2/2026
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DermaSarra, External Analgesic, (Camphor 0.5%) 222 mL (7.5 fl. oz.) per bottle, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047. NDC 61924-189-08 recalled?

Yes. FDA published recall D-0611-2025 on September 10, 2025. Reported hazard: Microbial Contamination of Non-Sterile Drug Product: The products were found to be contaminated with the bacteria Burkholderia cepecia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter